Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
American Journal of Clinical Dermatology|July 21, 2016
A Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with PsoriasisApril W Armstrong, Michael Bukhalo, Andrew BlauveltCutis|March 29, 2003
Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylureaMichael Bukhalo, Nathalie C Zeitouni, Richard T CheneyDermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 6, 2008
Topical hemostatic agents: a reviewMelanie D Palm, Jeffrey S AltmanDermatology (Basel, Switzerland)|May 31, 2002
A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgarisRachel S Altman, Lawrence J Altman, Jeffrey S AltmanThe Journal of Clinical and Aesthetic Dermatology|June 18, 2016
Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 StudyMark Lebwohl, Stephen Tyring, Michael Bukhalo, et al.Journal of Cutaneous Medicine and Surgery|January 28, 2022
Onset of Symptom Relief Reported in Daily Diaries of Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5)David Rosmarin, Marta Casillas, Sherry Chen, et al.Dermatology and Therapy|May 11, 2025
Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient OutcomesBruce E Strober, Michael Bukhalo, April W Armstrong, et al.Journal of Drugs in Dermatology : JDD|February 5, 2013
Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trialAlan Menter, Linda Stein Gold, Michael Bukhalo, et al.Dermatology Online Journal|November 4, 2020
Efficacy and safety of ingenol disoxate gel in field treatment of actinic keratosis on full face, scalp or large area (250 cm2) on the chest: results of four phase 3 randomized controlled trialsBrian Berman, Michael Bukhalo, C William Hanke, et al.Journal of Drugs in Dermatology : JDD|June 20, 2017
Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or ChestC William Hanke, Brian Berman, Neil Swanson, et al.Pageof 3